Kewaunee Scientific (KEQU) to release FY and Q4 2026 results June 23
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Kewaunee Scientific Corporation filed a current report stating it will release financial results for its fourth quarter and fiscal year ended April 30, 2026 on June 23, 2026 after the close of trading. The results will be posted on the company’s website.
The filing also highlights Kewaunee’s global business in laboratory, healthcare, and technical furniture, and notes its newly acquired subsidiary Nu Aire, a manufacturer of biological safety cabinets and other laboratory equipment. The press release includes standard forward-looking statement language outlining various business risks and uncertainties.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Results period end: April 30, 2026
Results release date: June 23, 2026
Company founding year: 1906
+3 more
6 metrics
Results period end
April 30, 2026
Fiscal year and fourth quarter end date
Results release date
June 23, 2026
Date company plans to release FY and Q4 2026 results
Company founding year
1906
Kewaunee Scientific founding year
Nu Aire founding year
1971
Nu Aire subsidiary founding year
Manufacturing facilities US
3 facilities
Statesville, North Carolina manufacturing sites
Manufacturing facilities India
1 facility
Bangalore, India manufacturing site
Key Terms
forward-looking statements, Private Securities Litigation Reform Act of 1995, Risk Factors, Force Majeure events, +1 more
5 terms
forward-looking statements regulatory
"This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Private Securities Litigation Reform Act of 1995 regulatory
"forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995."
Risk Factors regulatory
"Many important factors that could cause such a difference are described under the caption “Risk Factors,” in Item 1A of our Annual Report on Form 10-K for the most recent fiscal year ended April 30,"
Risk factors are elements or conditions that could cause an investment's value to decrease or lead to potential losses. They are like warning signs or obstacles that can affect the success of an investment, making it uncertain or more unpredictable. Recognizing risk factors helps investors understand the possible challenges and make more informed decisions.
Force Majeure events regulatory
"acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events."
biological safety cabinets technical
"Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products"
An enclosed, ventilated workspace that keeps lab workers, the surrounding environment, and delicate biological samples separate by controlling airflow and filtering out contaminants—think of it as a clean, protective box that prevents germs and particles from spreading. Investors care because these cabinets are required for safe research, clinical testing and manufacturing; their presence affects a lab’s ability to operate legally and reliably, influencing regulatory risk, operating costs and the pace at which scientific work can be commercialized.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 10, 2026
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (704 ) 873-7202
N/A
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. ☐
Item 8.01 Other Events
On June 10, 2026, Kewaunee Scientific Corporation announced that the Company plans to release results for its fourth quarter and fiscal year ended April 30, 2026 on June 23, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. | Description | |||||||
| 99.1 | Press Release of Kewaunee Scientific Corporation dated June 10, 2026. | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| KEWAUNEE SCIENTIFIC CORPORATION (Registrant) | |||||||||||
| Date: June 10, 2026 | By | /s/ Donald T. Gardner III | |||||||||
| Donald T. Gardner III | |||||||||||
| Vice President, Finance | |||||||||||
| Chief Financial Officer | |||||||||||
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter
Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III
704/871-3274
STATESVILLE, N.C. June 10, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2026 on Tuesday, June 23, 2026 after the close of trading. This information will be available on the Company’s website www.kewaunee.com after the release.
About Kewaunee Scientific
Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company’s corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, Spain, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
Kewaunee Scientific's newly acquired subsidiary, Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, Nu Aire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.
Learn more at the companies' websites, located at http://www.kewaunee.com and http://www.nuaire.com/.
This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands;
CORPORATE OFFICES ● P. O. BOX 1842, STATESVILLE, NORTH CAROLINA 28687-1842 ● 2700 WEST FRONT STREET, STATESVILLE, NORTH CAROLINA 28677-2927
PHONE 704-873-7202 ● FAX 704-873-1275
technological changes in our operations or in our industry; dependence on customers’ required delivery schedules; risks related to fluctuations in the Company’s operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders’ interest. Many important factors that could cause such a difference are described under the caption “Risk Factors,” in Item 1A of our Annual Report on Form 10-K for the most recent fiscal year ended April 30, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.
FAQ
When will Kewaunee Scientific (KEQU) report fiscal year 2026 results?
Kewaunee Scientific plans to release financial results for its fourth quarter and fiscal year ended April 30, 2026 on June 23, 2026 after the close of trading. The information will be available on the company’s website once released.
What period will Kewaunee Scientific’s upcoming KEQU earnings release cover?
The upcoming Kewaunee Scientific earnings release will cover the fourth quarter and full fiscal year ended April 30, 2026. The company stated these consolidated results will be made available on its website after they are released on June 23, 2026.
What does Kewaunee Scientific (KEQU) say about forward-looking statements?
Kewaunee Scientific explains that statements about future financial condition, operations, and prospects are forward-looking under the Private Securities Litigation Reform Act of 1995. It notes these statements involve risks, uncertainties, and assumptions that could cause actual results to differ materially.
What businesses and products does Kewaunee Scientific (KEQU) operate?
Kewaunee Scientific designs, manufactures, and installs laboratory, healthcare, and technical furniture, including casework, fume hoods, modular systems, and safety cabinets. Its Nu Aire subsidiary adds biological safety cabinets, CO2 incubators, ultralow freezers, and other laboratory products, broadening the combined portfolio for global customers.
Where are Kewaunee Scientific’s (KEQU) main operations located?
Kewaunee Scientific’s corporate headquarters are in Statesville, North Carolina, with three manufacturing facilities there and another in Bangalore, India. Sales offices operate in the United States, Spain, India, Saudi Arabia, and Singapore, supported by a warehouse partnership in the Netherlands and OEM partnerships in China.